已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

医学 心房颤动 肥厚性心肌病 导管消融 心脏病学 内科学 导管 烧蚀 心肌病 外科 心力衰竭
作者
Jordan M. Prutkin,David S. Owens
出处
期刊:Heart [BMJ]
卷期号:102 (19): 1513-1514 被引量:5
标识
DOI:10.1136/heartjnl-2016-309761
摘要

Atrial fibrillation (AF) is a well-recognised comorbidity in patients with hypertrophic cardiomyopathy (HCM), occurring in about 25% of patients.1 It is associated with increased mortality and worse heart failure symptoms, especially if there is concomitant outflow tract obstruction,2 and can be markedly debilitating in some individuals. The loss of atrial kick can reduce preload and worsen or unmask outflow obstruction, and higher ventricular rates can decrease cardiac outputs by reducing left ventricular (LV) filling time in the setting of diastolic dysfunction and reduced LV compliance. Rhythm control strategies are indicated with symptomatic AF, but the current antiarrhythmic choices are suboptimal. Patients with HCM have a propensity for both atrial and ventricular arrhythmias, and there is little data on the safety of antiarrhythmic therapies in this population. Disopyramide is perhaps the best studied agent and may concurrently help to mitigate outflow obstruction through its negative inotropic properties. However, its use is limited by anticholinergic effects and breakthrough AF is common. Amiodarone is more efficacious, but has well described toxicities and should be used cautiously in young individuals. Sotalol, dofetilide and dronedarone may also be considered, but there is less data supporting their use, and there must be caution in monitoring the QT interval with the first two agents and heart failure symptoms with the latter.3 ,4 In this setting, the use of an AF ablation strategy for rhythm control is quite attractive. HCM may manifest as progressive fibrosis and stiffening and any interventions that can slow AF progression would be beneficial, but evidence for the efficacy of AF ablation in HCM is also lacking. In their Heart publication, Providencia et al report a systematic review and meta-analysis of AF ablation in …
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一直向前发布了新的文献求助10
1秒前
1秒前
丘比特应助十四采纳,获得10
3秒前
3秒前
霜序完成签到,获得积分10
4秒前
5秒前
10秒前
12秒前
大模型应助小燕子采纳,获得10
14秒前
斯文的萧完成签到,获得积分10
14秒前
十四发布了新的文献求助10
15秒前
直觉发布了新的文献求助10
16秒前
16秒前
18秒前
小蘑菇应助漂亮白枫采纳,获得10
19秒前
Hello应助漂亮白枫采纳,获得10
19秒前
李健应助欣慰的剑鬼采纳,获得10
19秒前
小刘发布了新的文献求助10
21秒前
24秒前
25秒前
张昭蓉完成签到 ,获得积分10
26秒前
miles发布了新的文献求助10
30秒前
Hello应助猪蹄采纳,获得10
30秒前
顾众生发布了新的文献求助10
32秒前
32秒前
天天快乐应助科研通管家采纳,获得10
35秒前
Jasper应助科研通管家采纳,获得10
35秒前
深情安青应助科研通管家采纳,获得10
35秒前
35秒前
大个应助科研通管家采纳,获得10
35秒前
38秒前
38秒前
nihao完成签到 ,获得积分10
40秒前
晶晶发布了新的文献求助10
41秒前
小燕子发布了新的文献求助10
43秒前
43秒前
大学生发布了新的文献求助10
44秒前
浮生若梦发布了新的文献求助10
46秒前
谨慎雪碧发布了新的文献求助10
46秒前
慎默应助酷炫的冰淇淋采纳,获得10
48秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989868
求助须知:如何正确求助?哪些是违规求助? 3531994
关于积分的说明 11255752
捐赠科研通 3270793
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882215
科研通“疑难数据库(出版商)”最低求助积分说明 809208